MUSELLA, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 1.897
AS - Asia 1.233
EU - Europa 240
SA - Sud America 56
Continente sconosciuto - Info sul continente non disponibili 30
AF - Africa 23
OC - Oceania 5
Totale 3.484
Nazione #
US - Stati Uniti d'America 1.639
TR - Turchia 474
CN - Cina 355
SG - Singapore 318
CA - Canada 248
IT - Italia 119
BR - Brasile 46
DE - Germania 31
EU - Europa 28
HK - Hong Kong 27
GB - Regno Unito 15
IN - India 15
SC - Seychelles 13
IE - Irlanda 11
JP - Giappone 10
RU - Federazione Russa 10
SE - Svezia 10
BD - Bangladesh 9
PL - Polonia 8
ES - Italia 6
FR - Francia 5
MX - Messico 5
NL - Olanda 5
VN - Vietnam 5
AU - Australia 4
CH - Svizzera 4
FI - Finlandia 4
UA - Ucraina 4
UZ - Uzbekistan 4
IQ - Iraq 3
RO - Romania 3
ZA - Sudafrica 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
BO - Bolivia 2
CO - Colombia 2
DZ - Algeria 2
EC - Ecuador 2
EG - Egitto 2
IL - Israele 2
IR - Iran 2
LT - Lituania 2
MA - Marocco 2
NP - Nepal 2
PK - Pakistan 2
AT - Austria 1
BG - Bulgaria 1
CL - Cile 1
CR - Costa Rica 1
GD - Grenada 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KW - Kuwait 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SA - Arabia Saudita 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 3.484
Città #
San Mateo 448
Kocaeli 401
Toronto 226
Dallas 184
Wilmington 113
Singapore 104
Santa Clara 102
Houston 84
Lawrence 78
Princeton 78
Beijing 65
Ashburn 60
Chandler 54
Shanghai 41
Los Angeles 38
Rome 36
Hong Kong 25
Guangzhou 23
Seattle 19
The Dalles 19
Fairfield 18
Woodbridge 16
Columbus 15
Shenzhen 14
Brooklyn 11
West Jordan 10
Falls Church 9
Boston 8
Cambridge 8
São Paulo 8
Tokyo 8
Jiaxing 7
Milan 7
New York 7
Warsaw 7
Chicago 6
Montreal 6
Rui'an 6
San Francisco 6
Wuxi 6
Atlanta 5
Boardman 5
London 5
Stockholm 5
Viggiù 5
Xi'an 5
Council Bluffs 4
Florence 4
Helsinki 4
Palermo 4
Phoenix 4
Pune 4
Redwood City 4
Wuhan 4
Ankara 3
Belo Horizonte 3
Bern 3
Chennai 3
Dongyang 3
Kemerovo 3
Lariano 3
Las Vegas 3
Mexico City 3
Munich 3
Salt Lake City 3
Taizhou 3
Tashkent 3
Xuzhou 3
Al Qahirah al Jadidah 2
Alessandria 2
Amsterdam 2
Andover 2
Bengbu 2
Berlin 2
Brampton 2
Buffalo 2
Charlotte 2
Chengdu 2
Città di Castello 2
Dhaka 2
Dublin 2
Hanoi 2
Helena 2
Ho Chi Minh City 2
Hobart 2
Jinan 2
Johannesburg 2
Louisville 2
Manchester 2
Moscow 2
Nanchang 2
New Delhi 2
Pistoia 2
Secaucus 2
Turin 2
Vancouver 2
Washington 2
Abano Terme 1
Ahmedabad 1
Aimogasta 1
Totale 2.546
Nome #
4-Aminopyridine derivatives with anticholinesterase and antiamnesic activity 115
'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting 66
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis 63
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis 62
Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis 60
GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis 55
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome 55
Linking synaptopathy and gray matter damage in multiple sclerosis 54
Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis 54
Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions 53
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter 53
A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum 52
A Dynamic Splicing Program Ensures Proper Synaptic Connections in the Developing Cerebellum 52
Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum 51
Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis 51
Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis 50
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis 50
TNF-α-mediated anxiety in a mouse model of multiple sclerosis 49
Il-1β Dependent Cerebellar Synaptopathy in a Mouse Mode of Multiple Sclerosis 49
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis 49
Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis. 48
Behavioral and electrophysiological effects of endocannabinoid and dopaminergic systems on salient stimuli 48
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA 48
Interleukin-1β promotes long-term potentiation in patients with multiple sclerosis 47
Caffeine drinking potentiates cannabinoid transmission in the striatum: interaction with stress effects 47
Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis 46
Obesity worsens central inflammation and disability in multiple sclerosis 46
Before or after does it matter? Different protocols of environmental enrichment differently influence motor, synaptic and structural deficits of cerebellar origin 45
TRPV1 channels facilitate glutamate transmission in the striatum 45
Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination 45
Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis 44
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis 44
Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity 44
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis 44
Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis 44
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 44
Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis 43
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum 43
Adaptations of striatal endocannabinoid system during stress 43
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients 43
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis 43
Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis 42
Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons 42
Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation 42
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis 41
Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum 41
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 41
Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis 40
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum 40
Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum 39
MiR-142-3p is a key regulator of IL-1β-dependent synaptopathy in neuroinflammation 39
Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity 39
The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission 38
Re-Examining the Role of TNF in MS Pathogenesis and Therapy 38
Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake 38
Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study 36
Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum 36
Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis 36
Differences in spontaneously avoiding or approaching mice reflect differences in CB1-mediated signaling of dorsal striatal transmission 36
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 35
Cerebellar control of cortico-striatal LTD 35
Adaptations of glutamatergic synapses in the striatum contribute to recovery from cerebellar damage 35
Interleukin-1β causes anxiety by interacting with the endocannabinoid system 34
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 34
Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis 33
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 33
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis 32
Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis 32
Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum 31
Effects of caffeine on striatal neurotransmission: focus on cannabinoid CB1 receptors 31
Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis 31
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis 31
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 31
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 29
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis 28
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis 23
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis 22
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 22
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis 20
Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis 19
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 19
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 18
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 17
Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis 16
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis 16
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis 15
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis 15
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis 14
Preventive exercise and physical rehabilitation promote long‐term potentiation‐like plasticity expression in patients with multiple sclerosis 13
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis 12
Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression 12
Electrophysiology of Endocannabinoid Signaling 12
Interaction between miR-142-3p and BDNF Val/Met Polymorphism Regulates Multiple Sclerosis Severity 11
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation 11
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis 10
Special Issue Title: The neuroimmune crosstalk in mood disturbances of neurological and psychiatric diseases 10
Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients 10
Totale 3.643
Categoria #
all - tutte 39.604
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.604


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021602 0 34 5 1 27 25 33 9 16 13 403 36
2021/2022871 2 222 232 4 6 8 34 92 20 226 19 6
2022/2023306 179 4 4 19 8 14 0 9 10 19 23 17
2023/2024226 4 6 8 41 6 14 1 12 0 37 0 97
2024/20251.002 50 160 103 56 37 145 65 48 145 22 39 132
2025/2026403 155 248 0 0 0 0 0 0 0 0 0 0
Totale 3.643